Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrin

Miyuki Bohgaki, Masaki Matsumoto, Tatsuya Atsumi, Takeshi Kondo, Shinsuke Yasuda, Tetsuya Horita, Keiichi I. Nakayama, Fumihiko Okumura, Shigetsugu Hatakeyama, Takao Koike

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Antiphospholipid syndrome (APS) is characterized by thrombosis and the presence of antiphospholipid antibodies (aPL) that directly recognizes plasma β2-glycoprotein I (β2GPI). Tissue factor (TF), the major initiator of the extrinsic coagulation system, is induced on monocytes by aPL in vitro, explaining in part the pathophysiology in APS. We previously reported that the mitogen-activated protein kinase (MAPK) pathway plays an important role in aPL-induced TF expression on monocytes. In this study, we identified plasma gelsolin as a protein associated with β2GPI by using immunoaffinity chromatography and mass spectrometric analysis. An in vivo binding assay showed that endogenous β2GPI interacts with plasma gelsolin, which binds to integrin a5β1 through fibronectin. The tethering of β2GPI to monoclonal anti-β2GPI autoantibody on the cell surface was enhanced in the presence of plasma gelsolin. Immunoblot analysis demonstrated that p38 MAPK protein was phosphorylated by monoclonal anti-β2GPI antibody treatment, and its phosphorylation was attenuated in the presence of anti-integrin a5β1 antibody. Furthermore, focal adhesion kinase, a downstream molecule of the fibronectin-integrin signalling pathway, was phosphorylated by anti-β2GPI antibody treatment. These results indicate that molecules including gelsolin and integrin are involved in the anti-β2GPI antibody-induced MAPK pathway on monocytes and that integrin is a possible therapeutic target to modify a prothrombotic state in patients with APS.

Original languageEnglish
Pages (from-to)141-151
Number of pages11
JournalJournal of Cellular and Molecular Medicine
Volume15
Issue number1
DOIs
Publication statusPublished - Jan 1 2011

Fingerprint

Gelsolin
Integrins
Glycoproteins
Antiphospholipid Antibodies
Antiphospholipid Syndrome
Monocytes
Antibodies
Thromboplastin
Mitogen-Activated Protein Kinases
Fibronectins
Focal Adhesion Protein-Tyrosine Kinases
p38 Mitogen-Activated Protein Kinases
Autoantibodies
Chromatography
Proteins
Thrombosis
Therapeutics
Phosphorylation

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Cell Biology

Cite this

Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrin. / Bohgaki, Miyuki; Matsumoto, Masaki; Atsumi, Tatsuya; Kondo, Takeshi; Yasuda, Shinsuke; Horita, Tetsuya; Nakayama, Keiichi I.; Okumura, Fumihiko; Hatakeyama, Shigetsugu; Koike, Takao.

In: Journal of Cellular and Molecular Medicine, Vol. 15, No. 1, 01.01.2011, p. 141-151.

Research output: Contribution to journalArticle

Bohgaki, Miyuki ; Matsumoto, Masaki ; Atsumi, Tatsuya ; Kondo, Takeshi ; Yasuda, Shinsuke ; Horita, Tetsuya ; Nakayama, Keiichi I. ; Okumura, Fumihiko ; Hatakeyama, Shigetsugu ; Koike, Takao. / Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrin. In: Journal of Cellular and Molecular Medicine. 2011 ; Vol. 15, No. 1. pp. 141-151.
@article{eb5ba27e0aeb4ee28f250874f08f3ffa,
title = "Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrin",
abstract = "Antiphospholipid syndrome (APS) is characterized by thrombosis and the presence of antiphospholipid antibodies (aPL) that directly recognizes plasma β2-glycoprotein I (β2GPI). Tissue factor (TF), the major initiator of the extrinsic coagulation system, is induced on monocytes by aPL in vitro, explaining in part the pathophysiology in APS. We previously reported that the mitogen-activated protein kinase (MAPK) pathway plays an important role in aPL-induced TF expression on monocytes. In this study, we identified plasma gelsolin as a protein associated with β2GPI by using immunoaffinity chromatography and mass spectrometric analysis. An in vivo binding assay showed that endogenous β2GPI interacts with plasma gelsolin, which binds to integrin a5β1 through fibronectin. The tethering of β2GPI to monoclonal anti-β2GPI autoantibody on the cell surface was enhanced in the presence of plasma gelsolin. Immunoblot analysis demonstrated that p38 MAPK protein was phosphorylated by monoclonal anti-β2GPI antibody treatment, and its phosphorylation was attenuated in the presence of anti-integrin a5β1 antibody. Furthermore, focal adhesion kinase, a downstream molecule of the fibronectin-integrin signalling pathway, was phosphorylated by anti-β2GPI antibody treatment. These results indicate that molecules including gelsolin and integrin are involved in the anti-β2GPI antibody-induced MAPK pathway on monocytes and that integrin is a possible therapeutic target to modify a prothrombotic state in patients with APS.",
author = "Miyuki Bohgaki and Masaki Matsumoto and Tatsuya Atsumi and Takeshi Kondo and Shinsuke Yasuda and Tetsuya Horita and Nakayama, {Keiichi I.} and Fumihiko Okumura and Shigetsugu Hatakeyama and Takao Koike",
year = "2011",
month = "1",
day = "1",
doi = "10.1111/j.1582-4934.2009.00940.x",
language = "English",
volume = "15",
pages = "141--151",
journal = "Journal of Cellular and Molecular Medicine",
issn = "1582-1838",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrin

AU - Bohgaki, Miyuki

AU - Matsumoto, Masaki

AU - Atsumi, Tatsuya

AU - Kondo, Takeshi

AU - Yasuda, Shinsuke

AU - Horita, Tetsuya

AU - Nakayama, Keiichi I.

AU - Okumura, Fumihiko

AU - Hatakeyama, Shigetsugu

AU - Koike, Takao

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Antiphospholipid syndrome (APS) is characterized by thrombosis and the presence of antiphospholipid antibodies (aPL) that directly recognizes plasma β2-glycoprotein I (β2GPI). Tissue factor (TF), the major initiator of the extrinsic coagulation system, is induced on monocytes by aPL in vitro, explaining in part the pathophysiology in APS. We previously reported that the mitogen-activated protein kinase (MAPK) pathway plays an important role in aPL-induced TF expression on monocytes. In this study, we identified plasma gelsolin as a protein associated with β2GPI by using immunoaffinity chromatography and mass spectrometric analysis. An in vivo binding assay showed that endogenous β2GPI interacts with plasma gelsolin, which binds to integrin a5β1 through fibronectin. The tethering of β2GPI to monoclonal anti-β2GPI autoantibody on the cell surface was enhanced in the presence of plasma gelsolin. Immunoblot analysis demonstrated that p38 MAPK protein was phosphorylated by monoclonal anti-β2GPI antibody treatment, and its phosphorylation was attenuated in the presence of anti-integrin a5β1 antibody. Furthermore, focal adhesion kinase, a downstream molecule of the fibronectin-integrin signalling pathway, was phosphorylated by anti-β2GPI antibody treatment. These results indicate that molecules including gelsolin and integrin are involved in the anti-β2GPI antibody-induced MAPK pathway on monocytes and that integrin is a possible therapeutic target to modify a prothrombotic state in patients with APS.

AB - Antiphospholipid syndrome (APS) is characterized by thrombosis and the presence of antiphospholipid antibodies (aPL) that directly recognizes plasma β2-glycoprotein I (β2GPI). Tissue factor (TF), the major initiator of the extrinsic coagulation system, is induced on monocytes by aPL in vitro, explaining in part the pathophysiology in APS. We previously reported that the mitogen-activated protein kinase (MAPK) pathway plays an important role in aPL-induced TF expression on monocytes. In this study, we identified plasma gelsolin as a protein associated with β2GPI by using immunoaffinity chromatography and mass spectrometric analysis. An in vivo binding assay showed that endogenous β2GPI interacts with plasma gelsolin, which binds to integrin a5β1 through fibronectin. The tethering of β2GPI to monoclonal anti-β2GPI autoantibody on the cell surface was enhanced in the presence of plasma gelsolin. Immunoblot analysis demonstrated that p38 MAPK protein was phosphorylated by monoclonal anti-β2GPI antibody treatment, and its phosphorylation was attenuated in the presence of anti-integrin a5β1 antibody. Furthermore, focal adhesion kinase, a downstream molecule of the fibronectin-integrin signalling pathway, was phosphorylated by anti-β2GPI antibody treatment. These results indicate that molecules including gelsolin and integrin are involved in the anti-β2GPI antibody-induced MAPK pathway on monocytes and that integrin is a possible therapeutic target to modify a prothrombotic state in patients with APS.

UR - http://www.scopus.com/inward/record.url?scp=78751699828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751699828&partnerID=8YFLogxK

U2 - 10.1111/j.1582-4934.2009.00940.x

DO - 10.1111/j.1582-4934.2009.00940.x

M3 - Article

C2 - 19840195

AN - SCOPUS:78751699828

VL - 15

SP - 141

EP - 151

JO - Journal of Cellular and Molecular Medicine

JF - Journal of Cellular and Molecular Medicine

SN - 1582-1838

IS - 1

ER -